IP Library Assignment 022021/0606
Patent Assignment
Reel/Frame 022021/0606

Merger

Recorded: 2008-12-23 Pages: 33
Assignor
KIRIN PHARMA KABUSHIKI KAISHA
Executed: 2008-11-18
Assignee
KYOWA HAKKO KIRIN CO., LTD.
1-6-1, OHTEMACHI, CHIYODA-KU, TOKYO, JAPAN
Covered Properties (37)
Expression of Xenogenous (Human) Immunoglobulins in Cloned, Transgenic Ungulates
Methods for Altering Cell Fate
Methods for Cloning Mammals Using Reprogrammed Donor Chomatin or Donor Cells
Cloning of Transgenic Animals Comprising Artificial Chromosomes
Methods for Altering Cell Fate to Generate T- Cells Specific for an Antigen of Interest
Transgenic Ungulates Capable of Human Antibody Production
Transgenic Ungulates Having Reduced Prion Protein Activity and Uses Thereof
Transgenic Animals and Uses Thereof
Methods for Immunoglobulin Purification
Production of ungulates, preferably bovines that produce human immunoglobulins
Application: 09/714,185 →
Transgenic Bovine Comprising Human Immunoglobulin Loci and Producing Human Immunoglobulin
Patent: 7,074,983 →
Application: 09/988,115 →
Publication: US 2003/0037347
Methods for altering cell fate
Application: 10/015,824 →
Publication: US 2002/0142397
Methods for Cloning Non-Human Mammals Using Reprogrammed Donor Chromatin or Donor Cells
Patent: 7,253,334 →
Application: 10/032,191 →
Publication: US 2003/0046722
Methods for Altering Cell Fate to Generate T-Cells Specific for an Antigen of Interest
Patent: 7,491,534 →
Application: 10/426,595 →
Publication: US 2004/0072288
Transgenic Bovines Capable of Human Antibody Production
Patent: 7,414,170 →
Application: 10/441,503 →
Publication: US 2004/0068760
Cloning of Transgenic Unglulates Comprising Artificial Chromosomes
Patent: 7,652,192 →
Application: 10/468,951 →
Publication: US 2006/0294603
Transgenic Bovines Having Reduced Prion Protein Production
Patent: 7,429,690 →
Application: 10/705,519 →
Publication: US 2005/0097627
Methods for Altering Cell Fate
Patent: 7,736,895 →
Application: 10/910,156 →
Publication: US 2005/0014258
Production of ungulates, preferably bovines that produce human immunoglobulins
Application: 11/011,711 →
Publication: US 2005/0183145
Transgenic Animals and Uses Thereof
Patent: 7,420,099 →
Application: 11/111,310 →
Publication: US 2006/0041945
Methods for immunoglobulin purification
Application: 11/129,095 →
Publication: US 2005/0272917
Expression of Xenogenous (Human) Imunoglobulins in Cloned, Transgenic Ungulates
Patent: 7,491,867 →
Application: 11/291,668 →
Publication: US 2006/0117394
Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
Application: 11/292,164 →
Publication: US 2006/0117395
Methods for cloning mammals using reprogrammed donor chromatin or donor cells
Application: 11/439,788 →
Publication: US 2006/0212952
Expression of xenogeneic (Human) immunoglobulins in cloned, transgenic bovines
Application: 60/256,458 →
Methods for cloning mammals using reprogrammed donor chromatin
Application: 60/258,151 →
Methods for altering cell fate
Application: 60/258,152 →
Cloning of transgenic animals comprising artificial chromosomes
Application: 60/271,200 →
Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
Application: 60/311,625 →
Methods for altering cell fate to generate T-cells specific for an antigen of interest
Application: 60/376,653 →
Methods for reducing endogenous antibody in an ungulate that expresses both xenogenous antibody and endogenous antibody
Application: 60/381,531 →
Transgenic ungulates with reduced prion protein activity and uses thereof
Application: 60/425,056 →
Transgenic ungulates with reduced prion protein activity and uses thereof
Application: 60/506,901 →
IgM heavy chain-deficient ungulates and uses thereof
Application: 60/564,445 →
Multigenic and multiallelic targeting in non-human mammals
Application: 60/564,458 →
Methods for immunoglobulin purification
Application: 60/571,146 →
Production and characterization of prion protein-deficient bovines
Application: 60/657,186 →
Related Assignments (15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 27, 2006
From: BISHOP, MICHAEL D.
To: KIRIN BREWERY COMPANY, LIMITED; HEMATECH, LLC
Reel/Frame 018013/0743 →
Assignment of Assignor's Interest Sep 7, 2007
From: HEMATECH, LLC
To: KIRIN BEER KABUSHIKI KAISHA
Reel/Frame 019799/0712 →
Assignment of Assignor's Interest Sep 7, 2007
From: HEMATECH, LLC
To: KIRIN BEER KABUSHIKI KAISHA
Reel/Frame 019799/0665 →
Change of Name Mar 20, 2008
From: KIRIN BEER KABUSHIKI KAISHA
To: KIRIN HOLDINGS KABUSHIKI KAISHA
Reel/Frame 020686/0712 →
Assignment of Assignor's Interest Apr 9, 2008
From: NUCLEOTECH, LLC
To: KIRIN SD
Reel/Frame 020777/0522 →
Assignment of Assignor's Interest Sep 10, 2008
From: KIRIN HOLDINGS KABUSHIKI KAISHA
To: KIRIN PHARMA KABUSHIKI KAISHA
Reel/Frame 021508/0274 →
Merger Mar 13, 2009
From: KIRIN PHARMA CO., LTD.
To: KYOWA HAKKO KIRIN CO., LTD.
Reel/Frame 022390/0234 →
Assignment of Assignor's Interest Jun 24, 2011
From: KYOWA HAKKO KIRIN CO., LTD.
To: BIODAK, LLC
Reel/Frame 026495/0001 →
Assignment of Assignor's Interest Mar 8, 2013
From: KYOWA HAKKO KIRIN CO., LTD.
To: SANFORD APPLIED BIOSCIENCES, L.L.C.
Reel/Frame 029951/0691 →
Change of Name Jan 12, 2015
From: SANFORD APPLIED BIOSCIENCES, L.L.C.
To: SAB, LLC
Reel/Frame 034751/0027 →
Asset Contribution and Assumption of Liabilities Agreement Feb 13, 2019
From: BIODAK LLC
To: SAB BIOTHERAPEUTICS, INC.
Reel/Frame 048326/0877 →
Assignment of Assignor's Interest Mar 6, 2019
From: SAB BIOTHERAPEUTICS, INC.
To: SAB LLC
Reel/Frame 048511/0975 →
Corrective Assignment to Correct the Nature of Conveyance and Assignor's Name Previously Recorded on Reel 022390 Frame 0234. Assignor(S) Hereby Confirms the Change of Name. May 26, 2021
From: KYOWA HAKKO KOGYO CO., LTD.
To: KYOWA HAKKO KIRIN CO., LTD.
Reel/Frame 056583/0647 →
Assignment of Assignor's Interest Nov 19, 2021
From: KYOWA HAKKO KIRIN CO., LTD.
To: SANFORD APPLIED BIOSCIENCES, L.L.C.
Reel/Frame 058165/0667 →
Change of Name Nov 22, 2021
From: SANFORD APPLIED BIOSCIENCES, L.L.C.
To: SAB, LLC
Reel/Frame 058217/0993 →